Florence Ashley

Last updated

Ashley in 2020 Florence Ashley on Schulich Law.jpg
Ashley in 2020

Florence Ashley is a Canadian academic, activist [1] and law professor at the University of Alberta. [2] They specialize in trans law and bioethics. They have numerous academic publications, including a book on the law and policy of banning transgender conversion practices. [3] Florence served as the first openly transfeminine clerk at the Supreme Court of Canada. [2] They are a winner of the Canadian Bar Association SOGIC Hero Award. [4]

Contents

Biography

Personal life and education

Ashley came out as trans and transitioned in 2015. [5] They use singular they pronouns. [6]

Ashley attended McGill University in Montreal, Canada, where they graduated with a Bachelor of Civil Law and a Juris Doctor in 2017 and with a Master of Laws in bioethics in 2019. They earned a Doctor of Juridical Science from the University of Toronto Faculty of Law in 2023, where they were also a Junior Fellow of Massey College. [7] [8]

Career

In 2019, Ashley became the first known openly transgender clerk at the Supreme Court of Canada, where they worked in the chambers of Justice Sheilah Martin. [9] [5] During the same year, the Canadian Bar Association awarded Ashley the SOGIC Hero Award. [1] In 2023, they joined the University of Alberta Faculty of Law as an Assistant Professor. [10]

Ashley's work is cited in the World Professional Association for Transgender Health‘s Standards of Care for the Health of Transgender and Gender Diverse People Version 8. [11]

In 2022, Ashley published the book Banning transgender conversion practices: a legal and policy analysis. [12] The book is about conversion therapy for transgender people and studies how they can be legally banned, and what impact this ban would have on the countries which would decide to implement these laws. Ashley believes that conversion therapy needs to disappear and that a formal ban improves the situation without fully solving the issue. [13] They cite the Centre for Addiction and Mental Health in Toronto as an example of practices that were so bad, they served as a precedent to get conversion therapy banned in the province of Ontario. [12]

Ashley coined the term ‘gender modality’, [14] [15] which is increasingly cited and applied in trans health [16] and education literature, [17] and by governments [18] and courts. [19]

In 2023, Ashley was one of 21 members appointed to the World Health Organization's guideline development group concerning the health of trans and gender diverse people, [20] but as of 15 January 2024, they were no longer listed as a proposed member of that group due to a schedule conflict. [21]

Selected academic publications

Books

Articles

Essays

Related Research Articles

Conversion therapy is the pseudoscientific practice of attempting to change an individual's sexual orientation, romantic orientation, gender identity, or gender expression to align with heterosexual and cisgender norms. Methods that have been used to this end include forms of brain surgery, surgical or chemical (hormonal) castration, aversion therapy treatments such as electric shocks, nausea-inducing drugs, hypnosis, counseling, spiritual interventions, visualization, psychoanalysis, and arousal reconditioning. There is a scientific consensus that conversion therapy is ineffective at changing a person's sexual orientation or gender identity and that it frequently causes significant long-term psychological harm. The position of current evidence-based medicine and clinical guidance is that homosexuality, bisexuality, and gender variance are natural and healthy aspects of human sexuality. An increasing number of jurisdictions around the world have passed laws against conversion therapy.

Gender dysphoria (GD) is the distress a person experiences due to a mismatch between their gender identity—their personal sense of their own gender—and their sex assigned at birth. The term replaced the previous diagnostic label of gender identity disorder (GID) in 2013 with the release of the diagnostic manual DSM-5. The condition was renamed to remove the stigma associated with the term disorder. The International Classification of Diseases uses the term gender incongruence instead of gender dysphoria, defined as a marked and persistent mismatch between gender identity and assigned gender, regardless of distress or impairment.

<span class="mw-page-title-main">Transphobia</span> Anti-transgender prejudice

Transphobia consists of negative attitudes, feelings, or actions towards transgender people or transness in general. Transphobia can include fear, aversion, hatred, violence or anger towards people who do not conform to social gender roles. Transphobia is a type of prejudice and discrimination, similar to racism, sexism, or ableism, and it is closely associated with homophobia. People of color who are transgender experience discrimination above and beyond that which can be explained as a simple combination of transphobia and racism.

<span class="mw-page-title-main">Transgender rights in Canada</span> Rights of transgender individuals in Canada

Transgender rights in Canada, including procedures for changing legal gender and protections from discrimination, vary among provinces and territories, due to Canada's nature as a federal state. According to the 2021 Canadian census, 59,460 Canadians identify as transgender. Canada was ranked third in Asher & Lyric's Global Trans Rights Index in 2023.

Gender dysphoria in children (GD), also known as gender incongruence of childhood, is a formal diagnosis for distress caused by incongruence between assigned sex and gender identity in some pre-pubescent transgender and gender diverse children.

Kenneth J. Zucker is an American-Canadian psychologist and sexologist known for the living in your own skin model, a form of conversion therapy aimed at preventing pre-pubertal chidren from growing up transgender by modifying their gender identity and expression.

In the United States, the rights of transgender people vary considerably by jurisdiction. In recent decades, there has been an expansion of federal, state, and local laws and rulings to protect transgender Americans; however, many rights remain unprotected, and some rights are being eroded. Since 2020, there has been a national movement by conservative/right-wing politicians and organizations to target transgender rights. There has been a steady increase in the number of anti-transgender bills introduced each year, especially in Republican-led states.

<span class="mw-page-title-main">Transgender youth</span> Children and adolescents who are transgender

Transgender youth are children or adolescents who do not identify with the sex they were assigned at birth. Because transgender youth are usually dependent on their parents for care, shelter, financial support, and other needs, they face different challenges compared to adults. According to the World Professional Association for Transgender Health, the American Psychological Association, and the American Academy of Pediatrics, appropriate care for transgender youth may include supportive mental health care, social transition, and/or puberty blockers, which delay puberty and the development of secondary sex characteristics to allow children more time to explore their gender identity.

Puberty blockers are medicines used to postpone puberty in children. The most commonly used puberty blockers are gonadotropin-releasing hormone (GnRH) agonists, which suppress the natural production of sex hormones, such as androgens and estrogens. Puberty blockers are used to delay puberty in children with precocious puberty. They are also used to delay the development of unwanted secondary sex characteristics in transgender children, so as to allow transgender youth more time to explore their gender identity and have been shown to reduce depression and suicidality in transgender and nonbinary youth.The same drugs are also used in fertility medicine and to treat some hormone-sensitive cancers in adults.

Transgender health care includes the prevention, diagnosis and treatment of physical and mental health conditions for transgender individuals. A major component of transgender health care is gender-affirming care, the medical aspect of gender transition. Questions implicated in transgender health care include gender variance, sex reassignment therapy, health risks, and access to healthcare for trans people in different countries around the world. Gender affirming health care can include psychological, medical, physical, and social behavioral care. The purpose of gender affirming care is to help a transgender individual conform to their desired gender identity.

The participation of transgender people in competitive sports, a traditionally sex-segregated institution, is a controversial issue, particularly the inclusion of transgender women and girls in women's sports.

Transgender rights in Australia have legal protection under federal and state/territory laws, but the requirements for gender recognition vary depending on the jurisdiction. For example, birth certificates, recognised details certificates, and driver licences are regulated by the states and territories, while Medicare and passports are matters for the Commonwealth.

<span class="mw-page-title-main">Transgender rights in New Zealand</span>

Transgender and non-binary people in New Zealand face discrimination in several aspects of their lives. The law is unclear on the legal status of discrimination based on gender identity, and also for intersex people.

Detransition is the cessation or reversal of a transgender identification or of gender transition, temporarily or permanently, through social, legal, and/or medical means. The term is distinct from the concept of 'regret', and the decision may be based on a shift in gender identity, or other reasons, such as health concerns, social or economic pressure, discrimination, stigma, political beliefs, or religious beliefs.

Rapid-onset gender dysphoria (ROGD) is a controversial, scientifically unsupported hypothesis which claims that some adolescents identify as transgender and experience gender dysphoria due to peer influence and social contagion. ROGD is not recognized as a valid mental health diagnosis by any major professional associations. The APA, WPATH and 60 other medical professional organizations have called for its elimination from clinical settings due to a lack of reputable scientific evidence for the concept, major methodological issues in existing research, and its stigmatization of gender-affirming care for transgender youth.

<span class="mw-page-title-main">Genspect</span> Organization opposing transgender rights

Genspect is an international group founded in June 2021 by psychotherapist Stella O'Malley that has been described as gender-critical. Genspect opposes gender-affirming care, as well as social and medical transition for transgender people. Genspect opposes allowing transgender people under 25 years old to transition, and opposes laws that would ban conversion therapy on the basis of gender identity. Genspect also endorses the unproven concept of rapid-onset gender dysphoria (ROGD), which proposes a subclass of gender dysphoria caused by peer influence and social contagion. ROGD has been rejected by major medical organisations due to its lack of evidence and likelihood to cause harm by stigmatizing gender-affirming care.

<span class="mw-page-title-main">Transgender genocide</span> Characterization of discrimination against trans people

Transgender genocide or trans genocide is a term used by some scholars and activists to describe an elevated level of systematic discrimination and violence against transgender people.

<span class="mw-page-title-main">Society for Evidence-Based Gender Medicine</span> Group opposing gender-affirming care

The Society For Evidence-Based Gender Medicine (SEGM) is a non-profit organization that is known for its opposition to gender-affirming care for transgender youth and for engaging in political lobbying. The group routinely cites the unproven concept of rapid-onset gender dysphoria and mistakenly claimed that conversion therapy techniques are only practiced on the basis of sexual orientation rather than gender identity. SEGM is often cited in anti-transgender legislation and court cases, sometimes filing court briefs. It is not recognized as a scientific organization by the international medical community, and has been described as a "fringe medical organization".

Therapy First, originally named the Gender Exploratory Therapy Association (GETA), is a group created in 2021 by members of the Society for Evidence-Based Gender Medicine (SEGM) and Genspect to advocate gender exploratory therapy, which experts consider to be a form of conversion therapy.

The early 21st century saw a rise in and increasing organisation around anti-transgender sentiments in the United Kingdom, the most common strain being that of gender-critical feminism. This has led to some referring to the United Kingdom by the nickname "TERF Island".

References

  1. 1 2 Chouinard, Maryse (5 February 2019). "En-"gendering" change". National Magazine. Canadian Bar Association . Retrieved 4 November 2021.
  2. 1 2 "Florence Ashley | Directory@UAlberta". www.ualberta.ca. Archived from the original on 8 July 2023. Retrieved 8 July 2023.
  3. "Banning Transgender Conversion Practices". UBC Press. Archived from the original on 10 April 2022. Retrieved 7 April 2022.
  4. "Florence Ashley, LL.M., Receives the Sexual Orientation and Gender Identity Community Section Hero Award". www.cba.org. Archived from the original on 6 November 2021. Retrieved 7 April 2022.
  5. 1 2 ""À mon partenaire: avant de te rencontrer, je ne me pensais pas capable d'être trans et amoureuse"". Le Huffington Post (in French). 8 June 2019. Archived from the original on 4 November 2021. Retrieved 4 November 2021.
  6. "Banning transgender conversion practices: Florence Ashley's first book is an important legal and policy guide to eradicating them". www.nationalmagazine.ca. Archived from the original on 28 September 2022. Retrieved 7 August 2022.
  7. "Florence Ashley | University of Toronto Faculty of Law". law.utoronto.ca. Archived from the original on 6 February 2022. Retrieved 9 April 2022.
  8. "Dis son pronom: les mots de la non-binarité". Le Devoir (in French). 6 July 2021. Retrieved 4 November 2021.
  9. "Florence Ashley, JD, LLM". Center for Applied Transgender Studies. Archived from the original on 4 November 2021. Retrieved 4 November 2021.
  10. "Five distinguished legal scholars appointed to Faculty of Law". www.ualberta.ca. Archived from the original on 8 July 2023. Retrieved 8 July 2023.
  11. Coleman, E.; Radix, A. E.; Bouman, W. P.; Brown, G. R.; de Vries, A. L. C.; Deutsch, M. B.; Ettner, R.; Fraser, L.; Goodman, M.; Green, J.; Hancock, A. B.; Johnson, T. W.; Karasic, D. H.; Knudson, G. A.; Leibowitz, S. F. (19 August 2022). "Standards of Care for the Health of Transgender and Gender Diverse People, Version 8". International Journal of Transgender Health. 23 (sup1): S1–S259. doi:10.1080/26895269.2022.2100644. ISSN   2689-5269. PMC   9553112 . PMID   36238954.
  12. 1 2 "A new book on conversion practices examines exactly what trans people need from lawmakers". xtramagazine.com. 6 April 2022. Archived from the original on 2 October 2022. Retrieved 4 August 2022.
  13. "Banning transgender conversion practices: Florence Ashley's first book is an important legal and policy guide to eradicating them". www.nationalmagazine.ca. Retrieved 4 August 2022.
  14. Ashley, Florence (2022). "'Trans' is my gender modality". In Erickson-Schroth, Laura (ed.). Trans Bodies, Trans Selves. Oxford, U.K.: Oxford University Press. p. 22. ISBN   9780190092726.
  15. Ashley, Florence; Brightly-Brown, Shari; Rider, G. Nic (13 June 2024). "Beyond the trans/cis binary: introducing new terms will enrich gender research". Nature . 630 (8016): 293–295. Bibcode:2024Natur.630..293A. doi: 10.1038/d41586-024-01719-9 . PMID   38858484.
  16. Streed, Carl G; et al. (8 July 2021). "Assessing and Addressing Cardiovascular Health in People Who Are Transgender and Gender Diverse: A Scientific Statement From the American Heart Association". Circulation . 144 (6): e136–e148. doi:10.1161/CIR.0000000000001003. PMC   8638087 . PMID   34235936.
  17. "Transgender and Nonbinary Identities". Gender Identity. Planned Parenthood. Archived from the original on 11 June 2019. Retrieved 19 June 2024.
  18. "Classification of cisgender, transgender and non-binary". Standards, Data Sources, and Classifications: Statistical Classifications. Statistics Canada. 18 October 2021. Archived from the original on 12 June 2024. Retrieved 19 June 2024.
  19. Michel v. Graydon, 2SCR763 , 101(SCC2020), archived from the original.
  20. "WHO announces the development of a guideline on the health of trans and gender diverse people". www.who.int. Archived from the original on 7 January 2024. Retrieved 7 January 2024.
  21. "WHO GUIDELINES ON THE HEALTH OF TRANS AND GENDER DIVERSE PEOPLE" (PDF). who.int. Archived (PDF) from the original on 17 January 2024. Retrieved 17 January 2024.